BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Orthop. Dec 18, 2025; 16(12): 109963
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.109963
Table 1 Baseline demographic characteristics of study


Min-max
Median
mean ± SD/n (%)
Age55.0-83.065.065.3 ± 7.21
SexFemale25 (62.5)
Male15 (37.5)
OccupationUnemployed33 (82.5)
Active worker7 (17.5)
Educational statusUneducated1 (2.5)
Primary school14 (35)
Middle school10 (25)
High school12 (30)
University3 (7.5)
Sensory loss(-)24 (60)
(+)16 (40)
Incontinence(-)27 (67.5)
(+)13 (32.5)
Spinous process sensitivity(-)30 (75)
(+)10 (25)
Paravertebral muscle spasm(-)10 (25)
(+)30 (75)
Duration of pain30.0-450.0150.0216.1 ± 139.0
Hand-ground distance0.0-70.015.021.6 ± 20.9
Walking distance (m)10.0-600.0100.0143.8 ± 164.5
Visual pain score during movement5.0-10.08.08.1 ± 1.4
Visual pain score during resting0.0-8.03.53.4 ± 2.1
Visual pain score during night0.0-9.04.03.8 ± 2.8
ILBDI score11.0-81.040.040.1 ± 15.7
NEADL score12.0-56.031.533.4 ± 13.9
Symptom severity scale of SSS12.0-32.020.021.0 ± 5.4
Physical function scale of SSS5.0-90.010.014.5 ± 17.8
Table 2 Comparison of demographic characteristics in two groups
Surgery group
Conservative group
P value
n (%)
Median
n (%)
Median
Age (mean ± SD)63.7 ± 6.8063.567.1 ± 7.468.50.0961
SexFemale12 (60.0)13 (55.0)0.0742
Male8 (40.0)7 (35.0)
OccupationUnemployed15 (75.0)18 (90.0)0.2122
Active worker5 (25.0)2 (10.0)
Educational status
    Uneducated1 (5.0)0 (0.0)0.7442
    Primary school6 (30.0)8 (40.0)
    Middle school5 (25.0)5 (25.0)
    High school7 (35.0)5 (25.0)
    University1 (5.0)2 (10.0)
Incontinence(-)10 (50.0)17 (85.0)0.0182
(+)10 (50.0)3 (15.0)
Spinous process sensitivity(-)13 (65.0)17 (85.0)0.1442
(+)7 (35.0)3 (15.0)
Paravertebral Muscle spasm(-)3 (15.0)7 (35.0)0.1442
(+)17 (85.0)13 (65.0)
Duration of pain (mean ± SD)194.0 ± 153.3120.0238.3 ± 123.1200.00.1791
Hand-ground distance (mean ± SD)32.5 ± 21.930.010.8 ± 13.16.00.0011
Table 3 Comparison of walking distance and pain levels pre-treatment and at post-treatment 1 month and 1 year
Surgery group
Conservative group
P value
mean ± SD
Median
mean ± SD
Median
Walking distance (m)
Pre-treatment132.5 ± 182.550.0155.0 ± 148.3100.00.1731
Post-treatment 1st month241.8 ± 230.7150.0184.5 ± 135.4150.00.7431
Post treatment 1st year349.4 ± 259.8200.0255.3 ± 195.8150.00.2371
Change compared to pre-treatment
Post-treatment 1st month change109.3 ± 149.450.029.5 ± 31.530.00.1001
Intra-group change P value0.00120.0022
Post-treatment 1st year change200.0 ± 213.1100.099.4 ± 142.150.00.2111
Intra-group change P value0.00120.0042
Visual pain score during movement
Pre-treatment8.0 ± 1.18.08.2 ± 1.68.00.6281
Post-treatment 1st month5.8 ± 2.66.07.1 ± 1.57.00.1161
Post treatment 1st year5.5 ± 2.66.06.6 ± 2.27.00.2241
Change compared to pre-treatment
Post-treatment 1st month change-2.2 ± 2.5-1.5-1.1 ± 1.2-1.00.1891
Intra-group change P value0.0020.002
Post-treatment 1st year change-2.5 ± 2.6-2.0-1.7 ± 1.7-1.00.5941
Intra-group change P value0.00320.0032
Visual pain score during resting
Pre-treatment3.0 ± 2.23.03.9 ± 2.04.00.1851
Post-treatment 1st month1.3 ± 1.90.53.6 ± 2.53.50.0091
Post treatment 1st year1.1 ± 1.70.02.6 ± 2.72.00.1031
Change compared to pre-treatment
Post-treatment 1st month change-1.7 ± 1.7-2.0-0.4 ± 0.90.00.0121
Intra-group change P value0.00720.0832
Post-treatment 1st year change-1.6 ± 1.7-2.0-1.4 ± 1.7-1.00.8991
Intra-group change P value0.00620.002
Visual pain score during night
Pre-treatment3.6 ± 2.54.04.1 ± 3.03.00.6231
Post-treatment 1st month2.1 ± 2.21.53.7 ± 3.33.00.1321
Post treatment 1st year1.2 ± 1.70.03.2 ± 3.23.00.0581
Change compared to pre-treatment
Post-treatment 1st month change-1.5 ± 2.10.0-0.5 ± 1.10.00.1501
Intra-group change P value0.01120.0842
Post-treatment 1st year change-1.9 ± 2.30.0-1.2 ± 1.80.00.5491
Intra-group change P value0.00120.012
Table 4 Comparison of the groups' functional and daily living activity levels

Surgery group
Conservative group
P value
mean ± SD
Median
mean ± SD
Median
ILBDI score
Pre-treatment43.4 ± 17.44236.9 ± 13.5380.3791
Post-treatment 1st month34.8 ± 13.837.532.2 ± 13.534.50.4011
Post treatment 1st year31.2 ± 12.23031.4 ± 11.8280.7301
Change compared to Pre-treatment
Post-treatment 1st month change-8.6 ± 11.4-5.5-4.7 ± 5.4-20.4291
Intra-group change P value0.00120.0002
Post-treatment 1st year change-10.9 ± 12.6-4-4.2 ± 8.4-30.1561
Intra-group change P value0.00120.0752
NEADL score
Pre-treatment30.8 ± 14.125.536.0 ± 13.6350.2781
Post-treatment 1st month37.0 ± 14.238.541.4 ± 13.1430.3711
Post treatment 1st year39.2 ± 13.23938.5 ± 13.1370.7961
Change compared to pre-treatment
Post-treatment 1st month change6.2 ± 6.835.4 ± 7.720.5661
Intra-group change P value0.00120.0042
Post-treatment 1st year change8.2 ± 7.261.4 ± 7.810.0191
Intra-group change P value0.00120.4572
Symptom severity scale of SSS
Pre-treatment22.0 ± 5.42220.0 ± 5.4200.2381
Post-treatment 1st month17.3 ± 5.315.521.8 ± 6.6210.0181
Post treatment 1st year20.2 ± 5.72010.6 ± 4.690.0011
Change compared to pre-treatment
Post-treatment 1st month change-4.7 ± 4.5-41.7 ± 4.100.0011
Intra-group change P value0.00020.0422
Post-treatment 1st year change-1.5 ± 2.9-1-8.2 ± 4.2-90.0011
Intra-group change P value0.06320.0012
Physical function scale of SSS
Pre-treatment11.3 ± 3.21110.7 ± 4.290.2211
Post-treatment 1st month10.4 ± 5.3108.4 ± 2.380.0151
Post treatment 1st year10.8 ± 2.4101.5 ± 3.300.0011
Change compared to pre-treatment
Post-treatment 1st month change-0.8 ± 1.6-1-2.2 ± 3.2-1.50.2651
Intra-group change P value0.05420.0012
Post-treatment 1st year change-0.4 ± 2.40-9.3 ± 5.7-80.0011
Intra-group change P value0.51220.0002